NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

8302	Companies
115108	Keywords
55442	Articles
62528	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 06/12/2024 at 22:20, 5 months 8 days ago

Nanobiotix hosts virtual discussion on the potential of NBTXR3 in cancer treatments

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual Discussion
BRIEF

published on 06/12/2024 at 22:20, 5 months 8 days ago

Nanobiotix organise une discussion virtuelle sur le potentiel de NBTXR3 dans les traitements contre le cancer

Immunothérapie Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 Discussion Virtuelle
PRESS RELEASE

published on 06/12/2024 at 22:15, 5 months 8 days ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
PRESS RELEASE

published on 06/12/2024 at 22:15, 5 months 8 days ago

NANOBIOTIX ORGANISE UNE DISCUSSION VIRTUELLE ENTRE EXPERTS SUR LE POTENTIEL DE NBTXR3 EN IMMUNOTHÉRAPIE DANS LE CANCER DE LA TÊTE ET DU COU ET D’AUTRES INDICATIONS LE 18 JUIN 2024
Nanobiotix organise une discussion virtuelle entre experts sur le potentiel de NBTXR3 en immunothérapie dans le cancer de la tête et du cou et d'autres indications le 18 juin 2024

Immunothérapie Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 Discussion Virtuelle
BRIEF

published on 06/11/2024 at 22:20, 5 months 9 days ago

Nanobiotix: Monthly Information on Voting Rights and Shares

Voting Rights Euronext Actions Nasdaq NANOBIOTIX
BRIEF

published on 06/11/2024 at 22:20, 5 months 9 days ago

Nanobiotix : Informations Mensuelles sur les Droits de Vote et Actions

Droits De Vote Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 5 months 9 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses its voting rights and shares capital information as of May 31, 2024, in compliance with regulatory requirements. The company is a clinical biotechnology firm listed on Euronext Paris and Nasdaq

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 5 months 9 days ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Publication mensuelle du nombre total de droits de vote et d'actions de Nanobiotix le 31 mai 2024, conformément à la réglementation financière

Communication Financière Droits De Vote Capital Social Biotechnologie NANOBIOTIX
BRIEF

published on 06/02/2024 at 16:05, 5 months 19 days ago

Nanobiotix annonce des données prometteuses sur NBTXR3 pour les patients atteints d'un cancer de la tête et du cou

Essai Clinique Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 ASCO
BRIEF

published on 06/02/2024 at 16:05, 5 months 19 days ago

Nanobiotix Announces Promising Data on NBTXR3 for Head and Neck Cancer Patients

Clinical Trial Head And Neck Cancer NANOBIOTIX NBTXR3 ASCO

Accesswire

Published on 11/21/2024 at 20:15, 1 hour 28 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 1 hour 33 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 1 hour 43 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 2 hours 18 minutes ago

Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 4 hours 8 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 2 hours 42 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 3 hours 7 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 3 hours 45 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 3 hours 52 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 3 hours 52 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 14 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 45 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 1 hour ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 2 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE